ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells

Yunjie Xu(Jilin University), Liankun Sun(Jilin University)
International Journal of Oncology
July 9, 2018
Cited by 70


Related Papers